Group One Trading, L.P. Medpace Holdings, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $1.05 Million - $1.2 Million	-2,832 Reduced 99.02%	28 $11,000
Q1 2024 May 10, 2024	BUY	$284.87 - $413.31 $793,647 - $1.15 Million	2,786 Added 3764.86%	2,860 $1.16 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $16,836 - $23,138	74 New	74 $22,000
Q4 2022 Feb 09, 2023	BUY	$153.06 - $226.57 $84,183 - $124,613	550 New	550 $116,000
Q1 2021 May 12, 2021	SELL	$132.02 - $168.26 $26,404 - $33,652	-200 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$109.38 - $149.19 $10,938 - $14,919	-100 Reduced 33.33%	200 $28,000
Q3 2020 Nov 12, 2020	BUY	$92.95 - $130.61 $27,885 - $39,183	300 New	300 $34,000
Q1 2020 May 13, 2020	SELL	$61.71 - $101.95 $9,750 - $16,108	-158 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$70.08 - $84.64 $11,072 - $13,373	158 New	158 $13,000
Q2 2019 Aug 09, 2019	SELL	$53.64 - $65.42 $33,042 - $40,298	-616 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$49.38 - $70.58 $30,418 - $43,477	616 New	616 $36,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.